Sistemic Ltd. announce a milestone Global Service and License Agreement with Cynata Therapeutics Ltd. for the use of its SistemPSCCheck™ assay as part of the QCS release testing for CYP-001 and Cynata’s planned range of iPSC-derived products

Release Date: October 22, 2018

Glasgow, United Kingdom; 22nd October 2018: Sistemic Ltd. is pleased to announce the completion of a Global Service and License Agreement for its SistemPSCCheck™ assay with Australian stem cell and regenerative medicine company, Cynata Therapeutics Ltd. The agreement will see the use of the SistemPSCCheck™ assay for the assessment of residual pluripotent stem cells in Cynata’s current iPSC-derived MSC clinical candidate CYP-001, as well other planned iPSC-derived MSC products.

Sistemic Are Hiring!

Release Date: September 28, 2018

We are looking for 2 life sciences graduates to support development of our new SistemPSCCheck™ v1.0 service product. These are 12 month placements, with the potential to develop into a permanent roles. For full information, please visit Scotgrad via the links below: